A Huaier polysaccharide inhibits hepatocellular carcinoma growth and metastasis
- 315 Downloads
This study was carried out to evaluate the effects of a Huaier polysaccharide (TP-1) on the tumor growth and immune function in hepatocellular carcinoma (HCC) H22-based mouse in vivo. Results showed that TP-1 was capable of repressing transplanted H22 solid hepatic tumor cell growth in vivo, prolonging the live time of mice bearing ascetic H22 tumors, and repressing the pulmonary metastasis of H22-bearing mice. Moreover, the relative weight of immune organ (spleen and thymus) and lymphocyte proliferation were improved after TP-1 treatment. Furthermore, the treatment with TP-1 could promote immune-stimulating serum cytokines, such as IL-2 and IFN-γ, but inhibit immune-suppressing serum cytokines IL-10 secretion in H22-bearing mice. Besides, the percentage of CD4+ T cells and NK cells was increased, whereas the number of CD8+ T cells decreased in tumor-bearing mice following TP-1 administration. In addition, this compound displayed little toxic effects to major organ of tumor-bearing mice at the therapeutic dose, such as the liver and kidney. This experimental finding suggested that TP-1 exhibited prominent antitumor activities in vivo via enhancement of host immune system function in H22 tumor-bearing mice. This product could be developed individually as a safe and potent biological response modifier for HCC therapy.
KeywordsHuaier polysaccharide Antitumor Metastasis
This research is funded by National Natural Science Foundation of China (grant No. 81472328), Liver disease AIDS Foundation of You An Hospital, Capital Medical University (BJYAH-2011-034), National Science and Technology Support Project (2012BAI15B08), and Key Project of National Communicable Disease (2012ZX10002015-002).
Conflicts of interest
- 10.Zheng J, Li C, Wu X, Liu M, Sun X, Yang Y, et al. Astrocyte elevated gene-1 (AEG-1) shRNA sensitizes Huaier polysaccharide (HP)-induced anti-metastatic potency via inactivating downstream P13K/Akt pathway as well as augmenting cell-mediated immune response. Tumour Biol. 2014;35:4219–24.CrossRefPubMedGoogle Scholar
- 11.Wasser S. Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides. Appl Microbiol Biotechnol. 2003;60:258–74.Google Scholar
- 12.Staub AM. Removal of protein-Sevag method. Methods in Carbohydr Chem. 1965;5:5–6.Google Scholar
- 17.Singh SS, Haldar C, Rai S. Melatonin and differential effect of L-thyroxine on immune system of Indian tropical bird, Perdicula asiatica. Gen Comp Endocrinol. 2006;145:215–221.Google Scholar